Transcription of Guideline on good pharmacovigilance practices (GVP)
{{id}} {{{paragraph}}}
9 October 2017. EMA/827661/2011 Rev 1*. Guideline on good pharmacovigilance practices (GVP). Module IX Signal management (Rev 1). Date of coming into effect of first version 2 July 2012. Draft Revision 1* finalised by the Agency in collaboration with Member 30 June 2016. States Draft Revision 1 agreed by the European Risk Management Facilitation 18 July 2016. Group (ERMS FG). Draft Revision 1 adopted by Executive Director 4 August 2016. Release for public consultation 8 August 2016. End of consultation (deadline for comments) 14 October 2016. Revised draft Revision 1 finalised by the Agency in collaboration with 27 September 2017. Member States Revised draft Revision 1 agreed by the EU Network pharmacovigilance 4 October 2017. Oversight Group (EU-POG). Revised draft Revision 1 adopted by Executive Director as final 9 October 2017.
Draft Revision 1* finalised by the Agency in collaboration with Member States ; 30 June 2016. Draft Revision 1 agreed by the European Risk Management Facilitation
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}